Close

Publications

Benefits risk analysis of vaccination of pregnant women with rVSV-ZEBOV as part of expanded access programme.
EDMUNDS, J; JARVIS, C;
2018
(2018).
CROCKER-BUQUE, T; Edelstein, M; MOUNIER-JACK, S;
2018
Implementation science, (2018).13 1 10.1186/s13012-018-0824-8.
GALLAGHER, KE; KELLY, H; Cocks, N; Dixon, S; MOUNIER-JACK, S; HOWARD, N; WATSON-JONES, D;
2018
Papillomavirus research (Amsterdam, Netherlands), (2018).6, 10.1016/j.pvr.2018.10.004.
Benavente, ED; Oresegun, DR; De Sessions, PF; WALKER, EM; ROPER, C; Dombrowski, JG; De Souza, RM; Marinho, CR F; SUTHERLAND, CJ; HIBBERD, ML; Mohareb, F; BAKER, DA; CLARK, TG; CAMPINO, S;
2018
Scientific reports, (2018).8 1 10.1038/s41598-018-33767-3.
Kimaro Mlacha, SZ; Warira, A; Gatakaa, H; Goldblatt, D; SCOTT, JA G;
2018
Scientific reports, (2018).8 1 10.1038/s41598-018-33735-x.
A Clinical Trial of An Ebola Vaccine in Kambia, Sierra Leone.
WATSON-JONES, D;
2018
(2018).
BASU ROY, R; Whittaker, E; Seddon, JA; KAMPMANN, B;
2018
The Lancet. Infectious diseases, (2018).19 3 10.1016/S1473-3099(18)30157-9.
S1 Data File for: "Characterising antibody avidity in individuals of varied Mycobacterium tuberculosis infection status using surface plasmon resonance".
Scriba, TJ; Kimuda, SG; Biraro, IA; Bagaya, BS; RAYNES, JG; COSE, S;
2018
, PLOS One (2018).
Mauskopf, J; Standaert, B; Connolly, MP; Culyer, AJ; Garrison, LP; Hutubessy, R; JIT, M; Pitman, R; Revill, P; Severens, JL;
2018
Value in health, (2018).21 10 10.1016/j.jval.2018.08.005.